Abstract
In rodent models of type 2 diabetes (T2D), sustained remission of diabetic hyperglycemia can be induced by a single intracerebroventricular (icv) injection of fibroblast growth factor 1 (FGF1). To identify the brain areas responsible for this effect, we first used immunohistochemistry to map the hypothalamic distribution of phosphorylated extracellular signal-related kinase 1/2 (pERK1/2), a marker of mitogen-activated protein kinase-ERK signal transduction downstream of FGF receptor activation. Twenty minutes after icv FGF1 injection in adult male Wistar rats, pERK1/2 staining was detected primarily in two hypothalamic areas: the arcuate nucleus-median eminence (ARC-ME) and the paraventricular nucleus (PVN). To determine whether an action of FGF1 localized to either the ARC-ME or the PVN is capable of mimicking the sustained antidiabetic effect elicited by icv FGF1, we microinjected either saline vehicle or a low dose of FGF1 (0.3 µg/side) bilaterally into either the ARC-ME area or PVN of Zucker Diabetic Fatty rats, a model of T2D, and monitored daily food intake, body weight, and blood glucose levels over a 3-week period. Whereas bilateral intra-arcuate microinjection of saline vehicle was without effect, remission of hypergly...Continue Reading
References
Mar 10, 1997·The Journal of Comparative Neurology·N BelluardoK Fuxe
Jun 1, 2000·Metabolism: Clinical and Experimental·G J Etgen, B A Oldham
Apr 2, 2010·Diabetes·David A SarrufMichael W Schwartz
Dec 17, 2011·Science Translational Medicine·Ai-Luen WuJunichiro Sonoda
Dec 29, 2011·The Journal of Clinical Investigation·Joshua P ThalerMichael W Schwartz
Feb 14, 2013·Science Signaling·Malgorzata ZakrzewskaAntoni Wiedlocha
Oct 3, 2013·The Journal of Clinical Investigation·Gregory J MortonMichael W Schwartz
Jun 18, 2015·Journal of Cellular and Molecular Medicine·Roberto Elizondo-VegaMaria A García-Robles
Mar 12, 2016·Experimental & Molecular Medicine·Eun RohMin-Seon Kim
Mar 24, 2016·Proceedings of the National Academy of Sciences of the United States of America·Thomas H MeekGregory J Morton
May 24, 2016·Nature Medicine·Jarrad M ScarlettMichael W Schwartz
Feb 17, 2017·Glia·Heather BenfordNicholas Dale
Apr 26, 2017·PeerJ·Lisha ChoubeyKaren Müller Smith
Jun 13, 2017·Diabetes·Jennifer D DeemMichael W Schwartz
Oct 11, 2017·Cell Metabolism·Tian LanDavid J Mangelsdorf
Jan 31, 2018·ELife·Ana Covelo, Alfonso Araque
Mar 29, 2018·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Richard C RogersGerlinda E Hermann
Jun 7, 2018·Cell Metabolism·Martin ValdearcosSuneil K Koliwad
Dec 14, 2018·Diabetes·Jarrad M ScarlettMichael W Schwartz
Dec 12, 2018·Cell Metabolism·Marie Aare BentsenMichael W Schwartz
Citations
Sep 8, 2020·Diabetologia·Chelsea L FaberGregory J Morton
Jul 23, 2019·The Journal of Clinical Investigation·Jenny M BrownMichael W Schwartz
Sep 9, 2020·Nature Metabolism·Kimberly M AlongeMichael W Schwartz
Aug 6, 2019·The Journal of Clinical Investigation·Kerstin StemmerMatthias H Tschöp
Apr 26, 2020·Diabetes·Taylor LandryHu Huang
Sep 9, 2020·Nature Communications·Marie A BentsenTune H Pers
Oct 13, 2020·Diabetologia·Kimberly M AlongeMichael W Schwartz
Dec 11, 2020·Molecular Metabolism·Taylor LandryHu Huang
Apr 8, 2021·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Matei Bolborea, Fanny Langlet
Nov 5, 2020·Cell Metabolism·Giuseppe Gangarossa, Serge Luquet
Jun 22, 2021·Metabolism: Clinical and Experimental·Taylor LandryHu Huang
Jun 24, 2021·Nature Metabolism·Martin G MyersMichael W Schwartz
Aug 26, 2021·IScience·Jenny M BrownJarrad M Scarlett
Jan 7, 2022·Annual Review of Pharmacology and Toxicology·Zaman MirzadehMichael W Schwartz